首页> 美国卫生研究院文献>Molecules >Superior Stability of Hydroxysafflor Yellow A in Xuebijing Injection and the Associated Mechanism
【2h】

Superior Stability of Hydroxysafflor Yellow A in Xuebijing Injection and the Associated Mechanism

机译:血必净注射液中羟基红花黄色素A的优良稳定性及相关机制。

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Hydroxysafflor yellow A (HSYA) is the main bioactive ingredient of XBJ injection. At first, the stability of HSYA in solution and in a Xuebijing injection was investigated, then the mechanisms of the increased stability of HSYA in the XBJ injection were investigated to provide useful information on clinical safety. HSYA stability was investigated as a function of pH and temperature in aqueous solution and an XBJ injection, following the guidelines from the International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use. Products were identified by UPLC-MS/MS. HSYA reaction followed first-order kinetics under all conditions. The half-life of HSYA in XBJ was almost 40 times longer than in aqueous solution. The activation energies of HSYA reaction in aqueous solution and XBJ were calculated to be 78.53 and 92.90 kJ∙mol−1 by using Arrhenius equation. The results indicated that HSYA was more stable in XBJ than in aqueous solution. Two products were identified and the mechanism was intra-molecular nucleophilic substitution. The excellent stability of HSYA in XBJ injection partly due to the micelles formed in the injection. The study may provide clues for compatibility in TCM prescription and also provide useful information for further preparation technology research of HSYA and assessment of clinical safety of XBJ.
机译:羟基红花黄A(HSYA)是XBJ注射剂的主要生物活性成分。首先研究了HSYA在溶液中和血必净注射液中的稳定性,然后研究了在XBJ注射液中HSYA增加稳定性的机制,以提供有关临床安全性的有用信息。根据国际人用药品注册技术要求统一会议的指南,研究了HSYA稳定性与水溶液和XBJ注射液中pH和温度的关系。产品通过UPLC-MS / MS鉴定。在所有条件下,HSYA反应均遵循一级动力学。 XBJ中HSYA的半衰期几乎是水溶液的40倍。利用Arrhenius方程计算出HSYA反应在水溶液和XBJ中的活化能分别为78.53和92.90 kJ∙mol -1 。结果表明,HSYA在XBJ中比在水溶液中更稳定。鉴定出两种产物,其机理是分子内亲核取代。 HSYA在XBJ注射剂中的出色稳定性部分归因于注射剂中形成的胶束。该研究可为中药处方的相容性提供线索,也可为进一步的HSYA制备技术研究和XBJ临床安全性评估提供有用的信息。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号